Cargando…

The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology

Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exer...

Descripción completa

Detalles Bibliográficos
Autores principales: van Putten, Maaike, Hulsker, Margriet, Nadarajah, Vishna Devi, van Heiningen, Sandra H., van Huizen, Ella, van Iterson, Maarten, Admiraal, Peter, Messemaker, Tobias, den Dunnen, Johan T., 't Hoen, Peter A. C., Aartsma-Rus, Annemieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281102/
https://www.ncbi.nlm.nih.gov/pubmed/22359642
http://dx.doi.org/10.1371/journal.pone.0031937
_version_ 1782223921001529344
author van Putten, Maaike
Hulsker, Margriet
Nadarajah, Vishna Devi
van Heiningen, Sandra H.
van Huizen, Ella
van Iterson, Maarten
Admiraal, Peter
Messemaker, Tobias
den Dunnen, Johan T.
't Hoen, Peter A. C.
Aartsma-Rus, Annemieke
author_facet van Putten, Maaike
Hulsker, Margriet
Nadarajah, Vishna Devi
van Heiningen, Sandra H.
van Huizen, Ella
van Iterson, Maarten
Admiraal, Peter
Messemaker, Tobias
den Dunnen, Johan T.
't Hoen, Peter A. C.
Aartsma-Rus, Annemieke
author_sort van Putten, Maaike
collection PubMed
description Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist (Δhs)) with varying, low dystrophin levels (3–47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist (Δhs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist (Δhs) mice with 3–14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15–29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage.
format Online
Article
Text
id pubmed-3281102
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32811022012-02-22 The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology van Putten, Maaike Hulsker, Margriet Nadarajah, Vishna Devi van Heiningen, Sandra H. van Huizen, Ella van Iterson, Maarten Admiraal, Peter Messemaker, Tobias den Dunnen, Johan T. 't Hoen, Peter A. C. Aartsma-Rus, Annemieke PLoS One Research Article Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist (Δhs)) with varying, low dystrophin levels (3–47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist (Δhs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist (Δhs) mice with 3–14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15–29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage. Public Library of Science 2012-02-16 /pmc/articles/PMC3281102/ /pubmed/22359642 http://dx.doi.org/10.1371/journal.pone.0031937 Text en van Putten et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
van Putten, Maaike
Hulsker, Margriet
Nadarajah, Vishna Devi
van Heiningen, Sandra H.
van Huizen, Ella
van Iterson, Maarten
Admiraal, Peter
Messemaker, Tobias
den Dunnen, Johan T.
't Hoen, Peter A. C.
Aartsma-Rus, Annemieke
The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title_full The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title_fullStr The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title_full_unstemmed The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title_short The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
title_sort effects of low levels of dystrophin on mouse muscle function and pathology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281102/
https://www.ncbi.nlm.nih.gov/pubmed/22359642
http://dx.doi.org/10.1371/journal.pone.0031937
work_keys_str_mv AT vanputtenmaaike theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT hulskermargriet theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT nadarajahvishnadevi theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanheiningensandrah theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanhuizenella theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanitersonmaarten theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT admiraalpeter theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT messemakertobias theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT dendunnenjohant theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT thoenpeterac theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT aartsmarusannemieke theeffectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanputtenmaaike effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT hulskermargriet effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT nadarajahvishnadevi effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanheiningensandrah effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanhuizenella effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT vanitersonmaarten effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT admiraalpeter effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT messemakertobias effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT dendunnenjohant effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT thoenpeterac effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology
AT aartsmarusannemieke effectsoflowlevelsofdystrophinonmousemusclefunctionandpathology